Cambridge Healthtech Institute’s 13th Annual
Optimizing Cell Culture Technology
Enhancing Knowledge for Growing Cells
Part of CHI's Ninth Annual The Bioprocessing Summit
August 21-22, 2017 | Westin Copley Place | Boston, MA
The Optimizing Cell Culture Technology is the leading international conference focused solely on culturing cells. As industry needs increase, greater pressure is put on cell culture to meet growing demands. This meeting explores today’s evolving strategies and technologies for improving mammalian cell cultivation, including omics technologies and synthetic biology. Industry experts offer insights into optimizing conditions as well as cell biology in an effort to improve yield, while also addressing the future of cell culture in an expanding market where standards of quality continue to rise.
The agenda again features a session focused on CHO (Chinese Hamster Ovary cells), as well as small-group breakout discussions that provide the opportunity to discuss important topics with peers from around the world.
Genome Editing of CHO Cells: Molecular Tinkering or Revolutionary Change?
Alan Dickson, Ph.D., Director, Centre of Excellence in Biopharmaceuticals (COEBP), and Professor, Biotechnology, The University of Manchester
Genome Editing, NGS, microRNAs and Beyond: Transforming New Technologies into More Efficient CHO-K1 Manufacturing Cell Lines
Simon Fischer, Ph.D., Scientist, Boehringer Ingelheim Pharma GmbH & Co KG
Population Dynamics in Cloned CHO Cell Lines
Jennifer Tzihsuan Lin, Ph.D., Senior Scientist, Pfizer, Inc.
CRISPR Tools for CHO Cell Engineering
Helene Faustrup Kildegaard, Ph.D., Senior Researcher and Co-Principal Investigator, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Sub-Physiological Culture Temperature Boosts Expression Levels of Membrane Proteins in CHO Cells
Sampath Kumar, Ph.D., Senior Scientist II, Adimab LLC
BiP the Alarm; High Intracellular Seed Train BiP Levels Correlate with Poor Production Culture Performance, a Case Study of a DHFR-Deficient CHO Cell Line
Shahram Misaghi, Ph.D., Senior Scientist, Early Stage Cell Culture, Genentech -- A Member of the Roche Group
Use of Multivariate Data Analysis to Improve Cell Culture Performance in a Commercial Process
Betty Agudelo-Rewey, MS, Principal Engineer, Drug Substance Process Development, Amgen, Inc.
Softsensors: New Approach for Process Monitoring Cell Growth in Small-Scale Fermentation Systems
Wolfgang Paul, Ph.D., Group Leader, Cell Culture Research, Roche Innovation Center Munich, Roche Diagnostics GmbH
Achieving Seamless Scale-Up and Technology Transfer – A Case Study in Single-Use Bioreactors
Ying Wang, Ph.D., Senior Scientist I, Manufacturing Sciences - Cell Culture, AbbVie Bioresearch Center
Bioreactor Scale-Down Model Alterations to Better Predict Product Quality of Large Scale
Laurie Hazeltine, Ph.D., Research Scientist, Cell Culture – Late Phase, Eli Lilly and Company
For more details on the conference, please contact:
Senior Conference Director
For media partnership opportunities, please contact:
Director of Product Marketing
For exhibit & sponsorship opportunities, please contact:
Business Development Manager
Business Development Manager